Cantel Medical Corp. (CMD): Price and Financial Metrics


Cantel Medical Corp. (CMD): $80.37

-0.96 (-1.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CMD POWR Grades


  • CMD scores best on the Value dimension, with a Value rank ahead of 88.28% of US stocks.
  • CMD's strongest trending metric is Stability; it's been moving up over the last 31 weeks.
  • CMD's current lowest rank is in the Growth metric (where it is better than 28.03% of US stocks).

CMD Stock Summary

  • CMD's went public 28.29 years ago, making it older than 78.58% of listed US stocks we're tracking.
  • CMD's current price/earnings ratio is 65.32, which is higher than 85.62% of US stocks with positive earnings.
  • In terms of twelve month growth in earnings before interest and taxes, Cantel Medical Corp is reporting a growth rate of 121.54%; that's higher than 86.74% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Cantel Medical Corp are HLIO, AMEH, EPC, KEX, and AMN.
  • CMD's SEC filings can be seen here. And to visit Cantel Medical Corp's official web site, go to www.cantelmedical.com.

CMD Price Target

For more insight on analysts targets of CMD, see our CMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $62.00 Average Broker Recommendation 2 (Hold)

CMD Stock Price Chart Interactive Chart >

Price chart for CMD

CMD Price/Volume Stats

Current price $80.37 52-week high $89.76
Prev. close $81.33 52-week low $39.40
Day low $80.37 Volume 11,816,300
Day high $81.74 Avg. volume 626,604
50-day MA $83.98 Dividend yield N/A
200-day MA $68.59 Market Cap 3.58B

Cantel Medical Corp. (CMD) Company Bio


Cantel Medical Corporation provides infection prevention and control products and services in the healthcare market. The company operates in 5 segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, Specialty Packaging. The company was founded in 1963 and is based in Little Falls, New Jersey.

CMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$80.37$85.97 6%

Below please find a table outlining a discounted cash flow forecast for CMD, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Cantel Medical Corp ranked in the 55th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 6.5%. As for the metrics that stood out in our discounted cash flow analysis of Cantel Medical Corp, consider:

  • Its compound free cash flow growth rate, as measured over the past 5.45 years, is 0.27% -- higher than 65.12% of stocks in our DCF forecasting set.
  • Cantel Medical Corp's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 61.59% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Cantel Medical Corp has a reliance on debt greater than 74.37% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%4%
1%5%
2%6%
3%7%
4%8%
5%9%

Want more companies with a valuation profile/forecast similar to that of Cantel Medical Corp? See BIO, OMI, UNH, PNTG, and AMED.


CMD Latest News Stream


Event/Time News Detail
Loading, please wait...

CMD Latest Social Stream


Loading social stream, please wait...

View Full CMD Social Stream

Latest CMD News From Around the Web

Below are the latest news stories about Cantel Medical Corp that investors may wish to consider to help them evaluate CMD as an investment opportunity.

Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600

S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, June 2, 2021. STERIS plc (NYSE: STE) is acquiring Cantel Medical in a deal expected to be completed soon pending final closing conditions.

Yahoo | May 26, 2021

Mar Cor Launches Its Newest and Most Advanced Portable Reverse Osmosis Water System

Mar Cor launches the EON Portable RO Dialysis Water System. It produces high-quality medical water for acute and home hemodialysis use.

Yahoo | May 6, 2021

Announcing: Cantel Medical (NYSE:CMD) Stock Increased An Energizing 168% In The Last Year

When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...

Yahoo | April 28, 2021

Walgreens (WBA) Inks Deal to Expand COVID-19 Testing Access

Walgreens' (WBA) recent deal with Abbott is part of its ongoing efforts to offer greater testing access, helping reduce the spread of COVID-19 and improve the health of communities.

Yahoo | April 20, 2021

STERIS (STE) Hits a New 52-Week High: What's Driving It?

Investors are optimistic about STERIS (STE) backed by elevated consumer demand and strong segmental growth in third-quarter fiscal 2021.

Yahoo | April 19, 2021

Read More 'CMD' Stories Here

CMD Price Returns

1-mo -3.73%
3-mo 2.47%
6-mo 5.11%
1-year 93.62%
3-year -18.80%
5-year 11.73%
YTD 1.91%
2020 11.42%
2019 -4.53%
2018 -27.51%
2017 30.87%
2016 26.97%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8644 seconds.